Previous Article | Next Article 
Journal of Virology, October 1999, p. 8441-8447, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Altering the Intracellular Environment Increases
the Frequency of Tandem Repeat Deletion during Moloney Murine Leukemia
Virus Reverse Transcription
Julie K.
Pfeiffer,
Robert S.
Topping,
Nam-Hee
Shin, and
Alice
Telesnitsky*
Department of Microbiology and Immunology and
Comprehensive Cancer Center, University of Michigan Medical School, Ann
Arbor, Michigan 48109-0620
Received 19 March 1999/Accepted 2 July 1999
 |
ABSTRACT |
During retroviral DNA synthesis reverse transcriptase frequently
performs nonrequired template switches that can lead to genetic rearrangements or recombination. It has been postulated that template switching occurs after pauses in the action of reverse transcriptase. Hence factors which affect pausing, such as polymerization rate, may
affect the frequency of template switching. To address the hypothesis
that increasing the time required to complete reverse transcription
increases the frequency of template switching, we established
conditions that lengthened the time required to complete a single round
of intracellular Moloney murine leukemia virus reverse transcription
approximately threefold. Under these conditions, which resulted from
intracellular nucleotide pool imbalances generated with hydroxyurea, we
examined template switching frequency using a lacZ-based
tandem repeat deletion assay. We observed that the frequency of
deletion during reverse transcription in hydroxyurea-treated cells was
approximately threefold higher than that in untreated control cells.
These findings suggest that rates of retroviral recombination may vary
when the intracellular environment is altered.
 |
INTRODUCTION |
Retroviruses can persist in infected
cells in the form of double-stranded DNA copies of the viral RNA
genome. During reverse transcription, viral reverse transcriptase (RT)
must perform two template switches
the first and second strong-stop
template switches
to complete the synthesis of integration-competent
viral DNA (11). It has been postulated that the requirement
to perform these two obligatory template switches confers on RT the
tendency to make additional, nonrequired template switches which can
lead to viral genetic recombination (6, 32, 37). Paired with
RT's relatively high base substitution rate, such recombination events
are thought to introduce much of the genetic variation that is observed
in retroviral populations (15, 22, 30, 33). Both genetic alterations to RT and changes to the intracellular environment can
affect RT-mediated base substitution rates (21, 24, 29, 38).
However, factors that affect template switching during reverse
transcription remain largely unknown.
During recombinogenic template switching, RT begins DNA synthesis on
one copy of the viral genome and then switches to the other, copackaged
genome (intermolecular template switching). The frequency of
recombinogenic template switching varies, but experimental evidence
suggests that on average, such events happen roughly once per genome
per cycle of reverse transcription (19). RT can also perform
template switches between two different positions on the same template
molecule (intramolecular template switching). Homologous
recombination
template switching between regions with high sequence
similarity
is far more frequent than recombination between
nonhomologous sequences (15, 43, 44). In studies where
homology patterns should permit either type of switch, intramolecular template switching was much more common than intermolecular template switching (13).
Template switching during reverse transcription on templates containing
direct repeats frequently results in the deletion of one copy of the
repeat (3, 8, 13, 20, 22, 31, 32, 35, 36, 40). Spleen
necrosis virus-based vectors with direct repeats of 1,333, 788, and 383 bp have been shown to yield deleted products 93%, 85%, and 28 to 40%
of the time, respectively (20). Although recombination hot
spots have been characterized and template switching frequency does not
always reflect the length of sequence homology, direct-repeat deletion
rates are generally roughly proportional to the length of the direct
repeat (1, 19, 20, 31, 44).
Early models for retroviral template switching during minus strand
synthesis evoked the need for a template break to force transfer to the
homologous region of the copackaged genome (6). However, the
high frequency of tandem repeat deletions and the relatively minor
effects on recombination of experimental conditions designed to enhance
template lesions suggest that physical breaks in templates
although
possibly involved in some template switching
are not required
(14, 20, 40). It has also been suggested that kinetic
disruptions, such as pausing by RT, may promote departure from one
template and association with another. Support for this possibility
comes from observations that some template features, such as RNA
structures and homopolymeric runs, which may impede RT elongation, are
retroviral recombination hot spots (19, 31, 39). For many
types of polymerases, slowing of elongation can affect a wide range of
elongation properties. For example, there is a correlation between
decreased rates of elongation and pausing and/or termination for
Escherichia coli RNA polymerase. An RNA polymerase mutant
with decreased affinity for the substrates ATP and GTP showed a
decrease in elongation rate and increased pausing (18).
Additional studies in the E. coli system demonstrated that
elongation rate may determine the probability of transcript release and
that termination efficiency is indirectly proportional to the
elongation rate (17, 25). The authors of those studies noted
that small changes in the elongation rate of RNA polymerase can have
large effects on termination efficiency.
In this study we sought to address the effects of decreasing the RT
elongation rate on template switching events, such as those that lead
to retroviral genetic recombination. Previous determinations of rates
of retroviral recombination have been performed in transformed cells,
but viral replication in its natural setting occurs in cells whose
intracellular environments are less metabolically rich than those of
actively dividing cultured cells. In this study, hydroxyurea (HU) was
used to produce an imbalance of intracellular nucleotide pools and
template switching was scored by determining deletion rates of a 117-bp
direct repeat in a lacZ reporter gene. We found that HU
treatment lengthened the amount of time required to complete retroviral
DNA synthesis and that template switching frequency under these
conditions was increased threefold compared to that of untreated
control cells.
 |
MATERIALS AND METHODS |
Plasmid construction.
The gag-pol-puro plasmid,
pGPP, was a derivative of an infectious Moloney murine leukemia virus
(M-MuLV) provirus plasmid in which the env coding region was
replaced with an expression cassette for puromycin resistance. To make
pGPP, a BamHI-SpeI fragment containing the simian
virus 40 (SV40) promoter, a puromycin resistance gene, long terminal
repeats (LTRs), and plasmid backbone portions of pBabepuro
(26) was ligated to two restriction fragments, SpeI-SalI and SalI-BamHI,
which together contained the gag and pol portions
from the infectious M-MuLV provirus plasmid, pNCA (7).
pLacPuro and derivatives were M-MuLV-based vectors in which the viral
genes were replaced by the lacZ gene driven by the LTR promoter, followed by a puromycin resistance gene transcribed from the
SV40 promoter. pLacPuro contained the lacZ cassette from the
BAG vector (34) and the puromycin resistance gene from
pBabepuro in the "tipless" M-MuLV provirus backbone of pAM86-5
(23). An XbaI to HindIII fragment
including portions of the upstream LTR and the complete lacZ
gene from pBAG was combined with XbaI-EcoRI and
HindIII-EcoRI pAM86-5 fragments to yield
pLacPuro. To make different lengths of direct repeats within
lacZ, a restriction fragment containing the LacZ coding
region was further cleaved with different blunt-cutting restriction
enzymes. Pairwise combinations of upstream and downstream portions of
lacZ from different digests were then religated into the
parental vector so that 117-, 284-, and 971-bp direct repeats were made
(pLaac-117, pLaac-284, and pLaac-971, respectively). The 117-bp direct
repeat contained a duplication of sequences between EcoRV
and SspI, the 284-bp direct repeat contained a duplication
of sequences between HincII and FspI, and the
971-bp direct repeat contained a duplication of sequences between
EcoRV and FspI.
The pMLV


construct was made by deleting sequences
between
MscI and
AatII sites in the packaging
signal region of pNCA (
7,
10). Further construction details
are available on
request.
Cell lines and viruses.
NIH 3T3 cells were grown in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% calf
serum (Gibco). 293T cell derivatives (ET, ET pLacPuro, and ET pLaac
lines; see below) were grown in DMEM supplemented with 10% fetal
bovine serum (HyClone). Transfections were performed by using
lipofectamine (Gibco) according to the manufacturer's instructions,
except where noted. Infections were performed in the presence of 0.8 µg of hexadimethrine bromide (polybrene) (Sigma) per ml for either 10 min or 2 h at 37°C, as noted. Puromycin-resistant cells were
selected in puromycin (Sigma) at either 1-µg/ml (ET lines) or
6-µg/ml (3T3 cells) concentration.
To make the ET cell line, 293T cells were stably transfected with pAM
178, a plasmid that confers histidinol resistance and
contains the
ecotropic envelope gene driven by the cytomegalovirus
immediate-early
promoter. This plasmid was constructed by inserting
the
his
gene from pSV2 His and portions of pNCA that contain ecotropic
env into pCI (Promega). Construction details are available
on
request. Transfectants were single-cell cloned, and several cloned
transfectants were functionally tested for the ability to supply
ecotropic envelope in
trans by transiently transfecting them
with
pGPP and then testing the resulting virus for the ability to
confer
puromycin resistance on transduced 3T3 cells. The cell clone
that
consistently produced the largest number of puroR colonies was
used in subsequent experiments as the ET cell
line.
gag-pol-puro vector virus was generated by stably
transfecting ET cells with pGPP and pooling over 300 puromycin-resistant
colonies. Virus used in the timing of reverse
transcription experiments
was harvested from 80% confluent
100-mm-diameter plates of the
stably transfected pool every 12 h.
Collected virus was pooled,
filtered with 0.45-µm-pore-size filters
(Fisher), aliquoted, and
frozen at

70°C prior to
use.
To make LacPuro and Laac vector virus, pLacPuro and the various pLaac
plasmids were first stably transfected into ET cells.
Puromycin-resistant single-cell clones from these transfections
were
chosen as candidate ET-pLac and ET-pLaac vector-expressing
cell lines.
Candidate cell line genomic DNA was examined by Southern
blotting for
the presence of undeleted
lacZ. Each candidate cell
line was
further tested for vector integrity and functionality
by transiently
transfecting it with pMLV


, harvesting virus, and
using the vector virus to transduce fresh
3T3 cells. The resulting
puromycin-resistant colonies were stained
with X-Gal
(5-bromo-4-chloro-3-indolyl-

-
D-galactopyranoside)
to
detect functional LacZ. Suitable ET-derived single-cell-cloned
expressors of each vector were then chosen and called ET pLacPuro,
ET
pLaac-117, ET pLaac-284, and ET pLaac-971.
To generate virus for the assays of the rates of deletion, each line
(ET pLaac-117, ET pLaac-284, or ET pLaac-971) was transiently
transfected with pMLV


by using a calcium phosphate
precipitation method. Briefly, 5
µg of pMLV


plasmid
in 200 µl of 250 mM CaCl
2 was combined with 200 µl of
precipitation buffer (250 mM NaCl, 50 mM HEPES-NaOH [pH 7.1],
1.5 mM
Na
2HPO
4-NaH
2PO
4),
mixed well, and incubated for 30 min
at room temperature. Fresh
serum-containing medium (4 ml) was
applied to a 50% confluent
60-mm-diameter plate, and the DNA precipitate
was added dropwise. After
24 h, the medium was replaced with fresh
DMEM containing fetal
serum. Forty-eight hours after transfection,
5 ml of virus was
harvested, filtered, aliquoted, and stored at

70°C. The virus
samples used for all infections within each experiment
were from a
single stock of
virus.
Reverse transcription assays.
Reverse transcription was
timed by using virus from the ET gag-pol-puro cell line. 3T3
cells were infected with ET gag-pol-puro virus according to
the "short infection" protocol, which involved washing cells twice
with phosphate-buffered saline (PBS) 10 min after 50 µl of virus and
750 µl of complete medium containing 0.8 µg of polybrene per ml
were applied to the cells. After the wash step, cells either remained
untreated or were treated with 60 µM HU (Sigma). The media on all
plates were replaced at 5 h postinfection to remove HU. At
different times postinfection (1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 h)
cells were treated with 200 µM 3'-azido-3'-deoxythymidine (AZT)
(Sigma) to stop reverse transcription. At 48 h postinfection, the
media on all plates were replaced with puromycin-containing media.
After 2 weeks of puromycin selection the colonies were counted.
For experiments in which the times of HU exposure were varied, cells
were infected as described above and 60 µM HU was added
after
infection. HU-containing media were removed from these plates
at 5 or
10 h postinfection. AZT (200 µM) was added to the plates
at 2, 3, 4, 5, 7, 9, or 11 h postinfection. A control set of plates
received AZT but not HU at the same time points. Again, puromycin
was
added to the cells at 48 h postinfection and colonies were
counted
2 weeks later. Note that AZT was used only in assays of
the timing of
reverse transcription: in experiments where error
or deletion rates
were measured, no AZT was
added.
Rates of error during reverse transcription were examined by
determining rates of
lacZ inactivation of the wild-type
lacZ vector. The ET pLacPuro cell line was transiently
transfected
with pMLV


by the calcium phosphate
precipitation method described above.
Virus was harvested and used to
infect 3T3 cells as described
above. After the wash step, cells either
remained untreated or
were treated with 60 µM HU for 5 h, as
described above. After
2 weeks of puromycin selection, colonies were
stained with X-Gal.
The deletion frequencies of the different-sized direct repeats in
lacZ were analyzed by using virus produced from the ET pLaac
cell lines. Assays to examine rates of tandem repeat deletion
were
performed as follows. Fifty microliters of virus-containing
medium
harvested from pMLV


-transfected ET pLaac cells as
described above was combined with
750 µl of complete medium
containing polybrene, and the mix was
added to 20% confluent 3T3 cells
in a 60-mm-diameter culture dish.
After a 10-min incubation at 37°C,
the virus was removed and the
cells were washed twice with PBS. Three
milliliters of the appropriate
medium (with or without HU) was added to
each plate, and reverse
transcription was allowed to proceed at 37°C.
The medium on each
plate was replaced at 5 h postinfection to
eliminate HU. Forty-eight
hours after infection puromycin was added to
the plates, and puromycin-resistant
colonies were stained with X-Gal 2 weeks
later.
Deletion frequencies were adjusted to account for
lacZ-inactivating mutations. In our direct-repeat assays,
blue colonies
resulted when one copy of the vector's direct repeat was
deleted.
However, because the mutations that accumulate in intact
lacZ during a single cycle of viral replication (see Table
1) presumably
accumulate at the same rate regardless of whether a
deletion occurs,
we assume that some deleted vectors failed to generate
blue colonies
due to these additional mutations. Therefore, the ratios
of determinations
of deletion frequencies for the various pLaac vectors
for blue
colonies to the determinations for total colonies are likely
to
be underestimated. We corrected for these presumptive inactivating
mutations as follows: if the rate of
lacZ mutational
inactivation
was 8.8% and the blue-colony to total-colony ratio for
apparent
deletion frequency was 5.1%, we calculated that 5.1%
corresponded
to 91.2% of the total deletions and that the actual
deletion rate
was 5.6%. Since HU treatment resulted in increased rates
of
lacZ inactivation, the deletion frequencies for cells
treated with
HU were normalized by using an inactivation rate different
from
that used for untreated
cells.
For experiments on cells in serum at low concentration, cells were
grown in 0.5 or 10% calf serum-containing media for 48
h prior to
infection. Cells were then infected with ET pLaac virus
as described
above but did not receive HU. Forty-eight hours after
infection, fresh
medium containing 10% calf serum was added to
each plate. Puromycin
was added to the cells 48 h after infection,
and after 2 weeks of
selection colonies were stained with X-Gal.
LacZ staining was performed by using standard protocols
(
34). Briefly, cells were washed once with PBS. One
milliliter of
a fixing solution (2% formaldehyde, 0.2% glutaraldehyde
in PBS)
was added, and cells were incubated for 5 min at 4°C. Cells
were
then washed in PBS, and 1 ml of a staining solution (5 mM
potassium
ferricyanide, 5 mM potassium ferrocyanide, 2 mM
MgCl
2, 0.1% X-Gal
[Gibco BRL] in PBS) was
added.
 |
RESULTS |
Assessing the time required to complete intracellular reverse
transcription.
We developed an assay to gauge the length of time
required for the completion of a single round of viral DNA synthesis.
This assay involved infecting NIH 3T3 cells with replication-defective retroviral vectors that confer puromycin resistance, treating infected
cells with an excess of the RT inhibitor AZT at various times
postinfection, and then scoring whether viral DNA synthesis was
completed prior to AZT addition by determining the puromycin-resistant colony titer of the infected cells. For each of these timing assays, 3T3 cells were infected with gag-pol-puro vector virus
harvested as described in the Materials and Methods section (Fig.
1A). Because the cells were washed with
PBS at 10 min postinfection and the culture medium was replaced, most
infections should have been fairly synchronous and limited to virus
that had attached within the first 10 min. Under these conditions, the
productive multiplicity of infection was less than 0.01. At different
times after infection (1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 h), AZT
was added to separate plates. The concentration of AZT used was more
than 100-fold higher than that required to inhibit M-MuLV replication
(23a), but this amount of AZT does not cause apparent
cytopathology. Forty-eight hours after initial infection, the
AZT-containing medium was removed and puromycin-containing medium was
added. After 2 weeks of selection in puromycin, drug-resistant colonies
were counted. In this assay, only cells in which viral DNA synthesis
had been completed prior to AZT addition should form
puromycin-resistant colonies. In control experiments, where AZT was
added prior to infection, no puromycin-resistant colonies formed, thus
indicating that the concentration of AZT used in our assays completely
inhibited provirus generation.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 1.
Assay of timing of reverse transcription. (A) Schematic
overview of timing of reverse transcription assays. ET cells stably
expressing gag-pol-puro were used as a source of virus for
the timing assays. (ET cells are 293T cells that stably express
ecotropic Env.) 3T3 cells were infected for 10 min with ET
gag-pol-puro virus, and the cells were washed to remove most
unattached virions. After being washed, cells were treated with 60 µM
HU for 5 h or remained untreated. At various times postinfection,
200 µM AZT was added to individual plates. Puromycin was added to the
plates 48 h postinfection. Colonies were counted after 2 weeks of
selection. (B) Averaged results of two independent experiments
measuring timing of reverse transcription. The left half of the graph
shows results of experiments carried out in the absence of HU ( HU).
The positive control received no AZT, and the negative control (data
not shown) had no virus or AZT and no colonies were present. Numbers
1-10 denote the times of AZT addition (hours postinfection). The right
half of the graph shows results of experiments done in the presence of
60 µM HU (+HU). The positive control received HU but no AZT. For
these experiments, the media on all plates were changed at 5 h
postinfection. The average puromycin-resistant (puroR) colony titers
for positive controls in experiments conducted in the absence and
presence of HU were 2,290 and 1,640 colonies/ml, respectively, as
indicated above the bars. (C) Timing of reverse transcription with
varying times of HU exposure. Cells were infected as described for
panel B except that they were treated with 60 µM HU for 5 or 10 h or remained untreated ( HU). At various times postinfection (2, 3, 4, 5, 7, 9, or 11 h) 200 µM AZT was added to individual plates.
AZT was removed and puromycin was added after 48 h, and colonies
were counted 2 weeks later.
|
|
The left half of Fig.
1B shows a time course of AZT inhibition of
provirus synthesis and includes combined data obtained from
two
independent experiments. A few colonies were present on plates
which
had received AZT at 2 h postinfection, suggesting that DNA
synthesis was completed in less than 2 h for a small percentage
of
the virus. However, the majority of viral DNAs took at least
3 h
to complete. When the time point at which 50% of the positive
(no AZT)
control titer was formed was set as the mean DNA synthesis
completion
time, it appeared that the mean reverse transcription
time under our
standard assay conditions in 3T3 cells was 2 to
4
h.
Altering the intracellular environment to prolong the time required
to complete reverse transcription.
We also performed this assay
for the timing of reverse transcription in cells treated with HU. HU,
an inhibitor of cellular ribonucleotide reductase, has been shown to
inhibit reverse transcription by decreasing the levels of substrate
deoxynucleoside triphosphates (2, 12, 21). We performed
trials to determine a concentration of HU that partially inhibited
viral DNA synthesis. In the experiments described below, the same
infection protocol as described above was used except that 60 µM HU
was included in the culture media used after the postinfection wash
step. Again, AZT was added at different times after infection, and at
5 h the HU-containing medium was replaced with fresh medium.
Again, colonies were counted after 2 weeks of selection in puromycin.
The right half of Fig. 1B shows data obtained from two independent
experiments. Time courses of viral DNA completion in cells treated with
HU and in untreated cells are shown in this figure. At the 3-h time
point, untreated cells had completed synthesis of nearly half of the total viral DNAs, while less than 10% of the total DNAs had been synthesized in HU-treated cells at this time point. Colony counts gradually increased over successive time points of AZT addition for the
HU-treated cells, resulting in a mean completion time that was delayed
to more than 9 h. The titers of puromycin-resistant colonies in the
absence of AZT were only slightly higher for the untreated controls
than for the HU-treated cells (2,290 and 1,640 puromycin-resistant
colonies/ml, respectively), thus suggesting that the HU treatment
employed was not highly cytotoxic. It is possible that some component
of this modest titer decrease resulted from increased rates of abortive
reverse transcription rather than HU cytotoxicity.
Because the mean completion time determined as described above for
cells treated with HU was longer than the duration of HU
treatment, it
seemed possible that the observed delay may have
resulted from a
cessation of reverse transcription during HU exposure
followed by a
restoration of reverse transcription at the normal
rate when HU was
removed. To address this possibility, experiments
measuring the timing
of reverse transcription were performed as
described above except that
infected cells were exposed to HU
for 10 h, which is slightly
longer than the mean completion time
given above. AZT was added at 2, 3, 4, 5, 7, 9, or 11 h postinfection.
Figure
1C shows the results
of these experiments. Cells not treated
with HU showed a pattern for
DNA synthesis completion time similar
to that for cells not treated
with HU in the experiment summarized
in Fig.
1B, and the mean DNA
synthesis completion time was 2 to
4 h. Although overall colony
counts were reduced somewhat when
HU treatment time was increased,
cells treated with HU for 5 h
and those treated with HU for
10 h both showed comparable mean
completion times. Since the mean
completion time was reached during
the period of HU treatment for the
cells treated with HU for 10
h, reverse transcription was ongoing
during the period of HU treatment.
Since the times required to complete
DNA synthesis for both HU
treatment regimens were increased relative to
that for cells not
treated with HU, this suggests that on average, the
reverse transcription
machinery was engaged in the process of DNA
synthesis for a longer
period before completing viral DNA in cells
treated with HU than
in untreated
cells.
Analysis of reverse transcription error rates under altered
intracellular conditions.
We also analyzed the effect of HU
treatment on rates of error during reverse transcription by examining
rates of LacZ inactivation in a manner similar to that employed in
previously reported forward-mutation rate assays (21, 32).
To perform these experiments, we used LacPuro (Fig.
2B), a replication-defective retroviral
vector that confers puromycin resistance and encodes intact LacZ under
the control of the M-MuLV LTR promoter. Mammalian cells which have been
transduced with this vector stain blue with X-Gal unless the
lacZ gene has been mutationally inactivated. Virions
containing LacPuro were harvested as described in the Materials and
Methods section and used to infect 3T3 cells, either in the presence or absence of HU treatment for 5 h. After puromycin selection,
transduced cells were stained with X-Gal and blue and white colonies
were counted (Table 1). When the
criterion of LacZ inactivation was employed, untreated cells showed an
error rate of 8.8%, while HU-treated cells gave rise to an error rate
of 16.2%, which suggests that HU treatment during reverse
transcription increased the mutation rate roughly 1.8-fold. This value
is similar to a previously reported 2.7-fold increase in error rate
observed during the reverse transcription of murine leukemia virus
(MLV)-based vectors in 2 mM HU-treated D17 cells (21).
Although some of the white colonies in our experiments may have
resulted from effects such as the imbalanced expression that is
sometimes observed when two genes are coexpressed in a single
retroviral vector (9), we assumed that differences in white
colony/blue colony ratios in the presence and absence of HU resulted
from different levels of LacZ-inactivating errors during reverse
transcription.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Template switching assay and lacZ vectors.
(A) Template switching assay using the lacZ vectors
described in panel B. 293T cell-derived ET cells were transfected with
pLaac-117, pLaac-284, or pLaac-971, and stable clonal transfectants
were obtained by puromycin selection. pMLV  was then
transiently transfected into single-cell clones expressing each vector,
and virus was harvested and used to infect 3T3 cells. After puromycin
selection, the resulting 3T3 cell colonies were stained with X-Gal to
determine the deletion frequency. (B) M-MuLV-based vectors containing
direct repeats of different lengths within the lacZ gene.
The parental vector, pLacPuro, contains the puromycin resistance gene
transcribed from the SV40 promoter and the lacZ gene
transcribed from the upstream LTR. pLaac-117, pLaac-284, and pLaac-971
are derivatives of pLacPuro which contain 117-, 284-, and 971-bp
repeats, respectively, within the lacZ gene. LTRs are
represented by black boxes.
|
|
Establishing a system to measure rates of tandem repeat
deletion.
To assess rates of template switching during reverse
transcription, we constructed the Laac series of retroviral vectors. The plasmids which encode these were derivatives of pLacPuro with direct repeats of different lengths within the lacZ reporter
gene (Fig. 2B). If the direct repeat within lacZ remained
undeleted during reverse transcription, cells transduced by the
resulting vector DNA should remain unstained when incubated with X-Gal. However, if precise deletion of the direct repeat occurred during reverse transcription, then the transduced cells should stain blue.
We produced M-MuLV-derived virions containing Laac vector RNAs in human
293T cell-derived cells as described in the Materials
and Methods
section and used these to transduce fresh 3T3 cells
(Fig.
2A). These
virions should not reinfect the 293T cell-derived
producer cells
because the human cells lack the ecotropic receptor.
However, the virus
can be used to infect cells, such as murine
3T3 cells, which contain
the ecotropic receptor. After puromycin
selection, transduced 3T3 cells
were stained with X-Gal and the
numbers of blue and white colonies were
counted (Table
2). The
Laac vectors with
117-, 284-, and 971-bp direct repeats yielded
blue colony/total colony
ratios of 5.1, 27.1, and 60.0%, respectively.
If the measured LacZ
mutational inactivation rate of 8.8% given
above is factored in, then
these values suggest that the rates
of tandem deletion for the 117-, 284-, and 971-bp repeats were
roughly 5.6, 30, and 66%, respectively
(see the Materials and
Methods section). Thus, in agreement with data
presented by other
groups, our data revealed that deletion rates
increased with the
length of the direct repeats.
Comparing rates of tandem repeat deletion under differing
intracellular conditions.
To address whether increasing the
duration of reverse transcription affected template switching, rates of
tandem repeat deletion in HU-treated and untreated cells were compared.
For these experiments, Laac-117 vectors were chosen because their low
rate of blue colony formation (5.1%) should readily allow higher
deletion rates to be scored. 3T3 cells were infected with Laac-117
virus harvested from 293T cell-derived producer cells as described in
the Materials and Methods section. Reverse transcription was allowed to
proceed in either the presence or absence of 60 µM HU, the resulting
puromycin-resistant transductants were stained with X-Gal, and blue and
white colonies were counted. The results of 15 independent experiments
are listed in Table 3. In these assays,
untreated cells and HU-treated cells showed apparent template switching
frequencies of 5.0 and 13.5%, respectively, suggesting that HU
treatment increased template switching 2.7-fold. When calculated LacZ
inactivation rates were factored in (see the Materials and Methods
section), these findings suggest that direct-repeat deletion rates were
nearly threefold higher in HU-treated cells than in untreated cells.
 |
DISCUSSION |
We demonstrate here that alterations to the intracellular
environment can affect rates of tandem repeat deletion during M-MuLV reverse transcription. Specifically, we determined that treating cells
with HU resulted in an increase in tandem repeat deletion rates. The
design of this study was based on predictions of models for retroviral
genetic recombination and on known elongation properties of
polymerases. Viral template switching has been suggested to proceed by
a "pause and jump" mechanism, and polymerase elongation rates
affect pausing (27, 40). Therefore, we postulated that decreasing the rate of reverse transcription might increase template switching. Substrate limitations can reduce polymerase elongation rates, and HU treatment results in intracellular nucleotide pool imbalances. We thus sought to examine whether HU treatment affects template switching rates. We developed two main assays in the course of
this work: an intracellular vector DNA synthesis assay for timing of
the duration of reverse transcription and a lacZ-based tandem repeat deletion template switching assay.
The assay for timing of reverse transcription used AZT to terminate
vector DNA synthesis. The data suggested that the average time required
to complete reverse transcription of an 8.6-kb vector was 2 to 4 h
and that some DNA synthesis was completed within the first 1 or 2 h postinfection. These values are fairly consistent with the predicted
completion time, 2.4 h, for our vectors if intracellular
elongation proceeded at the rate, approximately 1 nucleotide/s, which
has been determined by using heteropolymeric primer and/or templates in
purified reaction mixtures (4, 16). It should be noted that
neither the time required for AZT-triphosphate formation in the cell
nor the times required for viral processes such as uncoating and
template switches are known precisely. However, we assume that the
times required for AZT triphosphorylation and viral entry did not vary
significantly among our experimental samples under our experimental
conditions and that hence the approach taken allowed us to compare
differences in duration of viral DNA synthesis.
Using this timing assay and a concentration of HU empirically
determined to partially inhibit viral DNA synthesis, we determined that
HU treatment resulted in a significantly prolonged mean completion time
of viral DNA synthesis. Whether the additional time required to
complete DNA synthesis was due to slowed DNA polymerization per se or
if other factors such as damage to template RNAs caused or contributed
to increased synthesis times was not explicitly examined. Because the
amounts of viral DNAs generated in our experiments were very small, our
attempts to monitor the accumulation of specific DNA intermediates over
time were not successful. However, our experiments suggest that
synthesis was ongoing throughout the period of HU treatment (Fig. 1c)
and hence our findings are consistent with the possibility that
synthesis of individual proviruses took longer in HU-treated cells than
in untreated cells.
The deletion of direct repeats is presumed to be mechanistically
related to the intermolecular template switching that results in
genetic recombination, and direct-repeat deletion has been used
frequently as a measure of intramolecular template switching. Therefore, a direct-repeat deletion assay was developed to score the
amounts of template switching in HU-treated and untreated cells. The
assay used retroviral vectors containing direct repeats of different
lengths in the lacZ gene, such that cells containing deleted
vectors stained blue with X-Gal while cells containing undeleted or
mutagenized lacZ regions remained unstained. Using this
approach, we demonstrated that treatment of cells with HU increased
template switching about threefold. These findings are consistent with
predictions derived from our hypothesis that decreasing reverse
transcription rates might increase template switching rates. However,
this increase may have resulted from either the increase in the time
required to complete DNA synthesis or other effects, such as a possible
increase in the number of broken RNA molecules, which some models
postulate to promote retroviral recombination (6). In
separate experiments, we altered intracellular conditions by growing
3T3 cells in 0.5% calf serum rather than our standard 10% calf serum.
We observed a twofold increase in template switching with the Laac-117
vector in cells fed 0.5% serum compared to that in cells fed 10%
serum (data not shown). This suggests that changes to the intracellular
environment other than HU treatment can also affect template switching
rates and hence that these effects are not specific to HU treatment.
The effects we report here have interesting implications for the
potential contributions of recombination to genetic variation in
retroviral populations. Rates of retroviral recombination have typically been assessed in cultured transformed cells, which are significantly more metabolically active than most cells that
retroviruses are likely to encounter during natural infection of an
organism. For example, replication of human immunodeficiency virus type 1 is slower in certain primary cells than in transformed cell lines
(28) and an interesting feature of human immunodeficiency virus is its ability to productively infect nondividing cells or to
partially reverse transcribe in quiescent cells (5, 41, 42).
Our findings suggest that proviruses generated under such conditions
may contain relatively high levels of RT-related errors, such as
template switch-induced recombination or other genomic rearrangements.
 |
ACKNOWLEDGMENTS |
We thank Vicki Larson for help with some early experiments and
Michael Imperiale and David Friedman for critical reading of the manuscript.
This work was supported by American Cancer Society grant
RPG-95-058-04-MBC to A.T. and NIH training grant T32 GM 07544 to J.K.P.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Michigan Medical School, 5641 Medical Sciences Bldg. II, Ann Arbor, MI 48109-0620. Phone: (734) 936-6466. Fax: (734) 764-3562. E-mail: ateles{at}umich.edu.
Present address: Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105.
 |
REFERENCES |
| 1.
|
Anderson, J. A.,
E. H. Bowman, and W.-S. Hu.
1998.
Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation.
J. Virol.
72:1195-1202[Abstract/Free Full Text].
|
| 2.
|
Back, N. K. T., and B. Berkhout.
1997.
Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.
Antimicrob. Agents Chemother.
41:2484-2491[Abstract].
|
| 3.
|
Bowman, R. R.,
W.-S. Hu, and V. K. Pathak.
1998.
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis.
J. Virol.
72:5198-5206[Abstract/Free Full Text].
|
| 4.
|
Buckle, M.,
R. M. Williams,
M. Negroni, and H. Buc.
1996.
Real time measurements of elongation by a reverse transcriptase using surface plasmon resonance.
Proc. Natl. Acad. Sci. USA
93:889-894[Abstract/Free Full Text].
|
| 5.
|
Bukrinsky, M. I.,
T. L. Stanwick,
M. P. Dempsey, and M. Stevenson.
1991.
Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.
Science
254:423-427[Abstract/Free Full Text].
|
| 6.
|
Coffin, J. M.
1979.
Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses.
J. Gen. Virol.
42:1-26[Abstract/Free Full Text].
|
| 7.
|
Colicelli, J., and S. P. Goff.
1988.
Sequence and spacing requirements of a retrovirus integration site.
J. Mol. Biol.
199:47-59[Medline].
|
| 8.
|
Delviks, K. A.,
W.-S. Hu, and V. K. Pathak.
1997.
-Vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.
J. Virol.
71:6218-6224[Abstract].
|
| 9.
|
Emerman, M., and H. M. Temin.
1984.
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.
Cell
39:459-467.
|
| 10.
|
Fisher, J., and S. P. Goff.
1998.
Mutual analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus.
Virology
244:133-145[Medline].
|
| 11.
|
Gilboa, E.,
S. W. Mitra,
S. Goff, and D. Baltimore.
1979.
A detailed model of reverse transcription and tests of crucial aspects.
Cell
18:93-100[Medline].
|
| 12.
|
Goulaouic, H.,
F. Subra,
J. F. Mouscadet,
S. Carteau, and C. Auclair.
1994.
Exogenous nucleosides promote the completion of MoMLV DNA synthesis in G0-arrested Balb c/3T3 fibroblasts.
Virology
200:87-97[Medline].
|
| 13.
|
Hu, W.-S.,
E. H. Bowman,
K. A. Delviks, and V. K. Pathak.
1997.
Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference.
J. Virol.
71:6028-6036[Abstract].
|
| 14.
|
Hu, W.-S., and H. M. Temin.
1992.
Effect of gamma radiation on retroviral recombination.
J. Virol.
66:4457-4463[Abstract/Free Full Text].
|
| 15.
|
Hu, W.-S., and H. M. Temin.
1990.
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.
Proc. Natl. Acad. Sci. USA
87:1556-1560[Abstract/Free Full Text].
|
| 16.
|
Huber, H. E.,
J. M. McCoy,
J. S. Seehra, and C. C. Richardson.
1989.
Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis and template switching.
J. Biol. Chem.
264:4669-4678[Abstract/Free Full Text].
|
| 17.
|
Jin, D. J.,
R. R. Burgess,
J. P. Richardson, and C. A. Gross.
1992.
Termination efficiency at rho-dependent terminators depends on kinetic coupling between RNA polymerase and rho.
Proc. Natl. Acad. Sci. USA
89:1453-1457[Abstract/Free Full Text].
|
| 18.
|
Jin, D. J., and C. A. Gross.
1991.
RpoB8, a rifampicin-resistant termination-proficient RNA polymerase, has an increased Km for purine nucleotides during transcription elongation.
J. Biol. Chem.
266:14478-14485[Abstract/Free Full Text].
|
| 19.
|
Jones, J. S.,
R. W. Allan, and H. M. Temin.
1994.
One retroviral RNA is sufficient for synthesis of viral DNA.
J. Virol.
68:207-216[Abstract/Free Full Text].
|
| 20.
|
Julias, J. G.,
D. Hash, and V. K. Pathak.
1995.
E vectors: development of novel self-inactivating and self-activating vectors for safer gene therapy.
J. Virol.
69:6839-6846[Abstract].
|
| 21.
|
Julias, J. G., and V. K. Pathak.
1998.
Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate.
J. Virol.
72:7941-7949[Abstract/Free Full Text].
|
| 22.
|
Katz, R. A., and A. M. Skalka.
1990.
Generation of diversity in retroviruses.
Annu. Rev. Genet.
24:409-445[Medline].
|
| 23.
|
Kulpa, D.,
R. Topping, and A. Telesnitsky.
1997.
Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors.
EMBO J.
16:856-865[Medline].
|
| 23a.
| Larson, V., and A. Telesnitsky. Unpublished data.
|
| 24.
|
Martin-Hernandez, A. M.,
E. Domingo, and L. Menendez-Arias.
1996.
Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis.
EMBO J.
15:4434-4442[Medline].
|
| 25.
|
McDowell, J. C.,
J. W. Roberts,
D. J. Jin, and C. Gross.
1994.
Determination of intrinsic transcription termination efficiency by RNA polymerase elongation rate.
Science
266:822-825[Abstract/Free Full Text].
|
| 26.
|
Morgenstern, J. P., and H. Land.
1990.
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
Nucleic Acids Res.
18:3587-3596[Abstract/Free Full Text].
|
| 27.
|
Nagy, P. D., and A. E. Simon.
1997.
New insights into the mechanisms of RNA recombination.
Virology
235:1-9[Medline].
|
| 28.
|
O'Brien, W. A.,
A. Namazi,
H. Kalhor,
S. H. Mao,
J. A. Zack, and I. S. Chen.
1994.
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.
J. Virol.
68:1258-1263[Abstract/Free Full Text].
|
| 29.
|
Pandey, V. N.,
N. Kaushik,
N. Rege,
S. G. Sarafianos,
P. N. S. Yadav, and M. J. Modak.
1996.
Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis.
Biochemistry
35:2168-2179[Medline].
|
| 30.
|
Parthasarathi, S.,
A. Varela-Echavarria,
Y. Ron,
B. D. Preston, and J. P. Dougherty.
1995.
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
J. Virol.
69:7991-8000[Abstract].
|
| 31.
|
Pathak, V. K., and H. M. Temin.
1990.
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions.
Proc. Natl. Acad. Sci. USA
87:6024-6028[Abstract/Free Full Text].
|
| 32.
|
Pathak, V. K., and H. M. Temin.
1990.
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.
Proc. Natl. Acad. Sci. USA
87:6019-6023[Abstract/Free Full Text].
|
| 33.
|
Preston, B. D., and J. P. Dougherty.
1996.
Mechanisms of retroviral mutation.
Trends Microbiol.
4:16-21[Medline].
|
| 34.
|
Price, J.,
D. Turner, and C. Cepko.
1987.
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.
Proc. Natl. Acad. Sci. USA
84:156-160[Abstract/Free Full Text].
|
| 35.
|
Pulsinelli, G. A., and H. M. Temin.
1991.
Characterization of large deletions occurring during a single round of retrovirus replication: novel deletion mechanism involving errors in strand transfer.
J. Virol.
65:4786-4797[Abstract/Free Full Text].
|
| 36.
|
Rhode, B. W.,
M. Emerman, and H. M. Temin.
1987.
Instability of large direct repeats in retrovirus vectors.
J. Virol.
61:925-927[Abstract/Free Full Text].
|
| 37.
|
Temin, H. M.
1993.
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation.
Proc. Natl. Acad. Sci. USA
90:6900-6903[Abstract/Free Full Text].
|
| 38.
|
Wainberg, M. A.,
W. C. Drosopoulos,
H. Salomon,
M. Hsu,
G. Borkow,
M. A. Parniak,
Z. Gu,
Q. Song,
J. Manne,
S. Islam,
G. Castriota, and V. R. Prasad.
1996.
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase.
Science
271:1282-1285[Abstract].
|
| 39.
|
Wooley, D. P.,
L. A. Bircher, and R. A. Smith.
1998.
Retroviral recombination is nonrandom and sequence dependent.
Virology
243:229-234[Medline].
|
| 40.
|
Xu, H., and J. D. Boeke.
1987.
High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
84:8553-8557[Abstract/Free Full Text].
|
| 41.
|
Zack, J. A.,
S. J. Arrigo,
S. R. Weitsman,
A. S. Go,
A. Haislip, and I. S. Y. Chen.
1990.
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
Cell
61:213-222[Medline].
|
| 42.
|
Zack, J. A.,
A. M. Haislip,
P. Krogstad, and I. S. Y. Chen.
1992.
Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.
J. Virol.
66:1717-1725[Abstract/Free Full Text].
|
| 43.
|
Zhang, J., and H. M. Temin.
1993.
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication.
Science
259:234-238[Abstract/Free Full Text].
|
| 44.
|
Zhang, J., and H. M. Temin.
1994.
Retrovirus recombination depends on the length of sequence identity and is not error prone.
J. Virol.
68:2409-2414[Abstract/Free Full Text].
|
Journal of Virology, October 1999, p. 8441-8447, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ibarra, K. D., Pfeiffer, J. K.
(2009). Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance. J. Virol.
83: 4538-4547
[Abstract]
[Full Text]
-
King, S. R., Duggal, N. K., Ndongmo, C. B., Pacut, C., Telesnitsky, A.
(2008). Pseudodiploid Genome Organization Aids Full-Length Human Immunodeficiency Virus Type 1 DNA Synthesis. J. Virol.
82: 2376-2384
[Abstract]
[Full Text]
-
Duggal, N. K., Goo, L., King, S. R., Telesnitsky, A.
(2007). Effects of Identity Minimization on Moloney Murine Leukemia Virus Template Recognition and Frequent Tertiary Template-Directed Insertions during Nonhomologous Recombination. J. Virol.
81: 12156-12168
[Abstract]
[Full Text]
-
Lanciault, C., Champoux, J. J.
(2006). Pausing during Reverse Transcription Increases the Rate of Retroviral Recombination. J. Virol.
80: 2483-2494
[Abstract]
[Full Text]
-
Onafuwa-Nuga, A. A., King, S. R., Telesnitsky, A.
(2005). Nonrandom Packaging of Host RNAs in Moloney Murine Leukemia Virus. J. Virol.
79: 13528-13537
[Abstract]
[Full Text]
-
Tipper, C. H., Bencsics, C. E., Coffin, J. M.
(2005). Characterization of Hortulanus Endogenous Murine Leukemia Virus, an Endogenous Provirus That Encodes an Infectious Murine Leukemia Virus of a Novel Subgroup. J. Virol.
79: 8316-8329
[Abstract]
[Full Text]
-
Lanciault, C., Champoux, J. J.
(2005). Effects of Unpaired Nucleotides within HIV-1 Genomic Secondary Structures on Pausing and Strand Transfer. J. Biol. Chem.
280: 2413-2423
[Abstract]
[Full Text]
-
Flynn, J. A., An, W., King, S. R., Telesnitsky, A.
(2004). Nonrandom Dimerization of Murine Leukemia Virus Genomic RNAs. J. Virol.
78: 12129-12139
[Abstract]
[Full Text]
-
Galetto, R., Moumen, A., Giacomoni, V., Veron, M., Charneau, P., Negroni, M.
(2004). The Structure of HIV-1 Genomic RNA in the gp120 Gene Determines a Recombination Hot Spot in Vivo. J. Biol. Chem.
279: 36625-36632
[Abstract]
[Full Text]
-
Nikolenko, G. N., Svarovskaia, E. S., Delviks, K. A., Pathak, V. K.
(2004). Antiretroviral Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Template-Switching Frequency. J. Virol.
78: 8761-8770
[Abstract]
[Full Text]
-
Duch, M., Carrasco, M. L., Jespersen, T., Aagaard, L., Pedersen, F. S.
(2004). An RNA secondary structure bias for non-homologous reverse transcriptase-mediated deletions in vivo. Nucleic Acids Res
32: 2039-2048
[Abstract]
[Full Text]
-
An, W., Telesnitsky, A.
(2004). Human Immunodeficiency Virus Type 1 Transductive Recombination Can Occur Frequently and in Proportion to Polyadenylation Signal Readthrough. J. Virol.
78: 3419-3428
[Abstract]
[Full Text]
-
Levy, D. N., Aldrovandi, G. M., Kutsch, O., Shaw, G. M.
(2004). From The Cover: Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. USA
101: 4204-4209
[Abstract]
[Full Text]
-
Cases-Gonzalez, C. E., Menendez-Arias, L.
(2004). Increased G->A Transition Frequencies Displayed by Primer Grip Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. J. Virol.
78: 1012-1019
[Abstract]
[Full Text]
-
Onafuwa, A., An, W., Robson, N. D., Telesnitsky, A.
(2003). Human Immunodeficiency Virus Type 1 Genetic Recombination Is More Frequent Than That of Moloney Murine Leukemia Virus despite Similar Template Switching Rates. J. Virol.
77: 4577-4587
[Abstract]
[Full Text]
-
Balakrishnan, M., Roques, B. P., Fay, P. J., Bambara, R. A.
(2003). Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis. J. Virol.
77: 4710-4721
[Abstract]
[Full Text]
-
An, W., Telesnitsky, A.
(2002). Effects of Varying Sequence Similarity on the Frequency of Repeat Deletion during Reverse Transcription of a Human Immunodeficiency Virus Type 1 Vector. J. Virol.
76: 7897-7902
[Abstract]
[Full Text]
-
Pfeiffer, J. K., Telesnitsky, A.
(2001). Effects of Limiting Homology at the Site of Intermolecular Recombinogenic Template Switching during Moloney Murine Leukemia Virus Replication. J. Virol.
75: 11263-11274
[Abstract]
[Full Text]
-
Hwang, C. K., Svarovskaia, E. S., Pathak, V. K.
(2001). Dynamic copy choice: Steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc. Natl. Acad. Sci. USA
10.1073/pnas.221289898v1
[Abstract]
[Full Text]
-
Robson, N. D., Telesnitsky, A.
(2000). Selection of Optimal Polypurine Tract Region Sequences during Moloney Murine Leukemia Virus Replication. J. Virol.
74: 10293-10303
[Abstract]
[Full Text]
-
Pfeiffer, J. K., Georgiadis, M. M., Telesnitsky, A.
(2000). Structure-Based Moloney Murine Leukemia Virus Reverse Transcriptase Mutants with Altered Intracellular Direct-Repeat Deletion Frequencies. J. Virol.
74: 9629-9636
[Abstract]
[Full Text]
-
Svarovskaia, E. S., Delviks, K. A., Hwang, C. K., Pathak, V. K.
(2000). Structural Determinants of Murine Leukemia Virus Reverse Transcriptase That Affect the Frequency of Template Switching. J. Virol.
74: 7171-7178
[Abstract]
[Full Text]
-
Shin, N.-H., Hartigan-O'Connor, D., Pfeiffer, J. K., Telesnitsky, A.
(2000). Replication of Lengthened Moloney Murine Leukemia Virus Genomes Is Impaired at Multiple Stages. J. Virol.
74: 2694-2702
[Abstract]
[Full Text]
-
Hwang, C. K., Svarovskaia, E. S., Pathak, V. K.
(2001). Dynamic copy choice: Steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc. Natl. Acad. Sci. USA
98: 12209-12214
[Abstract]
[Full Text]